Related Experiment Video

Updated: Jun 10, 2026

The Application Of Permanent Middle Cerebral Artery Ligation in the Mouse
08:27

The Application Of Permanent Middle Cerebral Artery Ligation in the Mouse

Published on: July 25, 2011

Pharmacological manipulation of brain glycogenolysis as a therapeutic approach to cerebral ischemia

Li Xu1, Hongbin Sun

  • 1Center for Drug Discovery, China Pharmaceutical University, 24 Tong Jia Xiang, Nanjing 210009, China.

Mini Reviews in Medicinal Chemistry
|August 19, 2010
PubMed

Insights

Inhibiting brain glycogenolysis offers a new therapeutic strategy for cerebral ischemia caused by stroke or cardiac arrest. This approach targets brain metabolism to protect against brain damage.

Area of Science:

  • Neuroscience
  • Metabolic pathways
  • Ischemic injury

Background:

  • Cerebral ischemia, often from cardiac arrest or stroke, is a major cause of death and disability.
  • Current pharmacological treatments for brain ischemia are limited.
  • Brain metabolism is a key factor in the consequences of cerebral ischemia.

Purpose of the Study:

  • To highlight the role of brain glycogen metabolism in cerebral ischemia.
  • To propose targeting glycogenolysis as a therapeutic strategy for brain ischemia.

Main Methods:

  • Review of brain glycogen metabolism.
  • Analysis of therapeutic potential of inhibiting glycogenolysis.

Main Results:

  • Brain glycogen metabolism plays a significant role in the response to ischemic events.
  • Inhibition of glycogenolysis presents a promising avenue for neuroprotection.

Conclusions:

  • Manipulating brain metabolism, specifically inhibiting glycogenolysis, offers a viable therapeutic approach for cerebral ischemia.
  • Further research into glycogenolysis inhibition could lead to effective treatments for stroke and traumatic brain injury.

More Related Videos

Hippocampal Insulin Microinjection and In vivo Microdialysis During Spatial Memory Testing10:32

Hippocampal Insulin Microinjection and In vivo Microdialysis During Spatial Memory Testing

Published on: January 11, 2013

A Model for Encephalomyosynangiosis Treatment after Middle Cerebral Artery Occlusion-Induced Stroke in Mice06:54

A Model for Encephalomyosynangiosis Treatment after Middle Cerebral Artery Occlusion-Induced Stroke in Mice

Published on: June 22, 2022

Related Concept Videos

Ischemic Stroke ll: Pathophysiology01:15

Ischemic Stroke ll: Pathophysiology

An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...